Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Companion Diagnostic Tests Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Companion Diagnostic Tests Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Companion Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Protein Detection
    • 1.4.3 DNA Detection
    • 1.4.4 Hybridization
    • 1.4.5 Biomarker
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Companion Diagnostic Tests Market Share by Application: 2020 VS 2026
    • 1.5.2 Pharmaceutical and Biotechnology Companies
    • 1.5.3 Medical Device Companies
    • 1.5.4 Research Institutes
  • 1.6 Coronavirus Disease 2019 (Covid-19): Companion Diagnostic Tests Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Companion Diagnostic Tests Industry
      • 1.6.1.1 Companion Diagnostic Tests Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Companion Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Companion Diagnostic Tests Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Companion Diagnostic Tests Market Perspective (2015-2026)
  • 2.2 Companion Diagnostic Tests Growth Trends by Regions
    • 2.2.1 Companion Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Companion Diagnostic Tests Historic Market Share by Regions (2015-2020)
    • 2.2.3 Companion Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Companion Diagnostic Tests Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Companion Diagnostic Tests Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Companion Diagnostic Tests Players by Market Size
    • 3.1.1 Global Top Companion Diagnostic Tests Players by Revenue (2015-2020)
    • 3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Companion Diagnostic Tests Market Concentration Ratio
    • 3.2.1 Global Companion Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests Revenue in 2019
  • 3.3 Companion Diagnostic Tests Key Players Head office and Area Served
  • 3.4 Key Players Companion Diagnostic Tests Product Solution and Service
  • 3.5 Date of Enter into Companion Diagnostic Tests Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Companion Diagnostic Tests Historic Market Size by Type (2015-2020)
  • 4.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2021-2026)

5 Companion Diagnostic Tests Breakdown Data by Application (2015-2026)

  • 5.1 Global Companion Diagnostic Tests Market Size by Application (2015-2020)
  • 5.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Companion Diagnostic Tests Market Size (2015-2020)
  • 6.2 Companion Diagnostic Tests Key Players in North America (2019-2020)
  • 6.3 North America Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 6.4 North America Companion Diagnostic Tests Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Companion Diagnostic Tests Market Size (2015-2020)
  • 7.2 Companion Diagnostic Tests Key Players in Europe (2019-2020)
  • 7.3 Europe Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 7.4 Europe Companion Diagnostic Tests Market Size by Application (2015-2020)

8 China

  • 8.1 China Companion Diagnostic Tests Market Size (2015-2020)
  • 8.2 Companion Diagnostic Tests Key Players in China (2019-2020)
  • 8.3 China Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 8.4 China Companion Diagnostic Tests Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Companion Diagnostic Tests Market Size (2015-2020)
  • 9.2 Companion Diagnostic Tests Key Players in Japan (2019-2020)
  • 9.3 Japan Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 9.4 Japan Companion Diagnostic Tests Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Companion Diagnostic Tests Market Size (2015-2020)
  • 10.2 Companion Diagnostic Tests Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Companion Diagnostic Tests Market Size by Application (2015-2020)

11 India

  • 11.1 India Companion Diagnostic Tests Market Size (2015-2020)
  • 11.2 Companion Diagnostic Tests Key Players in India (2019-2020)
  • 11.3 India Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 11.4 India Companion Diagnostic Tests Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Companion Diagnostic Tests Market Size (2015-2020)
  • 12.2 Companion Diagnostic Tests Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Companion Diagnostic Tests Market Size by Type (2015-2020)
  • 12.4 Central & South America Companion Diagnostic Tests Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 F. Hoffman LA Roche Ltd.
    • 13.1.1 F. Hoffman LA Roche Ltd. Company Details
    • 13.1.2 F. Hoffman LA Roche Ltd. Business Overview and Its Total Revenue
    • 13.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Introduction
    • 13.1.4 F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2015-2020))
    • 13.1.5 F. Hoffman LA Roche Ltd. Recent Development
  • 13.2 QIAGEN, Illumina, Inc.
    • 13.2.1 QIAGEN, Illumina, Inc. Company Details
    • 13.2.2 QIAGEN, Illumina, Inc. Business Overview and Its Total Revenue
    • 13.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Introduction
    • 13.2.4 QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.2.5 QIAGEN, Illumina, Inc. Recent Development
  • 13.3 Abbott
    • 13.3.1 Abbott Company Details
    • 13.3.2 Abbott Business Overview and Its Total Revenue
    • 13.3.3 Abbott Companion Diagnostic Tests Introduction
    • 13.3.4 Abbott Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.3.5 Abbott Recent Development
  • 13.4 Agilent Technologies, Inc.
    • 13.4.1 Agilent Technologies, Inc. Company Details
    • 13.4.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
    • 13.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Introduction
    • 13.4.4 Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.4.5 Agilent Technologies, Inc. Recent Development
  • 13.5 Genomic Health, Inc.
    • 13.5.1 Genomic Health, Inc. Company Details
    • 13.5.2 Genomic Health, Inc. Business Overview and Its Total Revenue
    • 13.5.3 Genomic Health, Inc. Companion Diagnostic Tests Introduction
    • 13.5.4 Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.5.5 Genomic Health, Inc. Recent Development
  • 13.6 BioMerieux SA, BioGenex
    • 13.6.1 BioMerieux SA, BioGenex Company Details
    • 13.6.2 BioMerieux SA, BioGenex Business Overview and Its Total Revenue
    • 13.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Introduction
    • 13.6.4 BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.6.5 BioMerieux SA, BioGenex Recent Development
  • 13.7 AGENDIA NV
    • 13.7.1 AGENDIA NV Company Details
    • 13.7.2 AGENDIA NV Business Overview and Its Total Revenue
    • 13.7.3 AGENDIA NV Companion Diagnostic Tests Introduction
    • 13.7.4 AGENDIA NV Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.7.5 AGENDIA NV Recent Development
  • 13.8 Siemens Healthcare GmBH
    • 13.8.1 Siemens Healthcare GmBH Company Details
    • 13.8.2 Siemens Healthcare GmBH Business Overview and Its Total Revenue
    • 13.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Introduction
    • 13.8.4 Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.8.5 Siemens Healthcare GmBH Recent Development
  • 13.9 Thermo Fisher Scientific, Inc.
    • 13.9.1 Thermo Fisher Scientific, Inc. Company Details
    • 13.9.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
    • 13.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Introduction
    • 13.9.4 Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
    • 13.9.5 Thermo Fisher Scientific, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Companion Diagnostic Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Tests development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    F. Hoffman LA Roche Ltd.
    QIAGEN, Illumina, Inc.
    Abbott
    Agilent Technologies, Inc.
    Genomic Health, Inc.
    BioMerieux SA, BioGenex
    AGENDIA NV
    Siemens Healthcare GmBH
    Thermo Fisher Scientific, Inc.

    Market segment by Type, the product can be split into
    Protein Detection
    DNA Detection
    Hybridization
    Biomarker
    Others
    Market segment by Application, split into
    Pharmaceutical and Biotechnology Companies
    Medical Device Companies
    Research Institutes

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Companion Diagnostic Tests status, future forecast, growth opportunity, key market and key players.
    To present the Companion Diagnostic Tests development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Companion Diagnostic Tests are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now